Integrated analysis of microRNA and mRNA expression profiles highlights the complex and dynamic behavior of toosendanin-induced liver injury in mice

被引:0
作者
Xiaoyan Lu
Cai Ji
Wei Tong
Xueping Lian
Ying Wu
Xiaohui Fan
Yue Gao
机构
[1] Pharmaceutical Informatics Institute,Department of Pharmacology and Toxicology
[2] College of Pharmaceutical Sciences,undefined
[3] Zhejiang University,undefined
[4] Beijing Institute of Radiation Medicine,undefined
来源
Scientific Reports | / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Triterpenoid Toosendanin (TSN) exhibits a plenty of pharmacological effects in human and great values in agriculture. However, the hepatotoxicity caused by TSN or Melia-family plants containing TSN used in traditional Chinese medicine has been reported and the mechanisms of TSN-induced liver injury (TILI) still remain largely unknown. In this study, the dose- and time-dependent effects of TSN on mice liver were investigated by an integrated microRNA-mRNA approach as well as the general toxicological assessments. As the results, the dose- and time-dependent liver injury and alterations in global microRNA and mRNA expressions were detected. Particularly, 9-days 80 mg/kg TSN exposure caused most serious liver injury in mice and the hepatic adaptation to TILI was unexpectedly observed after 21-days 80 mg/kg TSN administration. Based on the pathway analysis of the intersections between predicted targets of differentially expressed microRNAs and differentially expressed mRNAs at three time points, it revealed that TILI may be caused by glutathione depletion, mitochondrial dysfunction and lipid dysmetabolism, ultimately leading to hepatocytes necrosis in liver, while liver regeneration may play an important role in the hepatic adaptation to TILI. Our results demonstrated that the integrated microRNA−mRNA approach could provide new insight into the complex and dynamic behavior of TILI.
引用
收藏
相关论文
共 128 条
[1]  
Leise MD(2014)Drug-induced liver injury Mayo Clin. Proc. 89 95-106
[2]  
Poterucha JJ(2008)Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in the United States Gastroenterology 135 1924-1934
[3]  
Talwalkar JA(2012)A prospective nationwide study of drug-induced liver injury in Korea Am. J. Gastroenterol. 107 1380-1387
[4]  
Chalasani N(2013)Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients Eur. J. Gastroenterol. Hepatol. 25 825-829
[5]  
Suk KT(2014)Overview of Drug-Induced Liver Injury in China Clin. Liver Dis. 4 26-29
[6]  
Zhou Y(2007)Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine Prog. Neurobiol. 82 1-10
[7]  
Yang L(2010)Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis Planta Med. 76 1447-1453
[8]  
Liao Z(2005)Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine Invest. New Drugs 23 547-553
[9]  
He X(2004)Involvement of cytochrome c release and caspase activation in toosendanin-induced PC12 cell apoptosis Toxicology 201 31-38
[10]  
Guo H(2012)The apoptotic effects of toosendanin are partially mediated by activation of deoxycytidine kinase in HL-60 cells PLoS One 7 e52536-238